Riskpilot← Back to searchSign inGet full accessBIOHACK AS
ASActiveOrg 920964567Holmenkollveien 125Q, 0787 OsloRetail sale of other food · NACE 4727Est. 20180 employeesbiohack.no
Revenue 2024
NOK 36K
-45% vs 2023
EBITDA margin
-82.6%
-241% vs 2023
Equity ratio
-226.1%
Financial strength
Net profit 2024
NOK -30K
-243% vs 2023
| Revenue | NOK 36K | -45% |
| EBITDA | NOK -30K | -241% |
| Net profit | NOK -30K | -243% |
| Total assets | NOK 6K | -62% |
| Equity | NOK -14K | -186% |
| Employees | 0 | — |
Legal name
BIOHACK AS
Org number
920964567
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
12. juni 2018
Share capital
NOK 60 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selskapets virksomhet er å gjøre bedrifter mer attraktive og skape økt kundetilfredshet med digitale løsninger og annet som naturlig faller sammen med dette, samt nettbasert handel med kosttilskudd, biohacking-produkter, helserelaterte gadgets og livsstilsprodukter. Selskapet tilbyr et kuratert utvalg varer med fokus på personlig ytelse, helse og velvære, og leverer direkte til forbruker via egen nettplattform. Virksomheten kan drives i norge og utlandet.
Address
Holmenkollveien 125Q, 0787 Oslo
Website
biohack.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 163 | 347 | 36 | 4 | 0 | 66 | 36 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 | −39 | 8 | −17 | −11 | 21 | −30 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 | −39 | 8 | −17 | −11 | 21 | −30 |
| Net financials | 0 | 0 | 0 | 0 | 0 | −0 | −0 |
| Profit before tax | 1 | −39 | 8 | −17 | −11 | 21 | −30 |
| Tax | 0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −39 | 8 | −17 | −11 | 21 | −30 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 85 | 21 | 29 | 11 | 1 | 16 | 6 |
| Equity | 55 | 16 | 24 | 6 | −5 | 16 | −14 |
| Long-term debt | 30 | 5 | 5 | 5 | 5 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 1 | 0 | 20 |
| Total debt | 30 | 5 | 5 | 5 | 6 | 0 | 20 |
EBITDA margin
-82.6%
This company
15.8%
Market median
-623% vs market
20182024
Equity ratio
-226.1%
This company
38.2%
Market median
-692% vs market
20182024
Return on equity
-3000200.0%
This company
18.4%
Market median
-16305535% vs market
20182024
Net profit margin
-82.9%
This company
8.1%
Market median
-1123% vs market
20182024
Asset turnover
5.90×
This company
1.12×
Market median
+427% vs market
20182024
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KR Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOHACK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kai Remy Nyberg Kleven | Chief Executive Officer | 0 companies |
| Bjørn-Eirik Sakshaug | Board of Directors | 0 companies |
| Sindre Bach | Chairman | 0 companies |